Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Schwartsmann

Showing results (31-40 of 89) with videos related to

Pageof 9
Sort By:
Cancer Letters|October 26, 1999
Phenotype modulation of cellular UV-sensitivityM A Castro, G Schwartsmann, E A Bernard, et al.
Clinical and Experimental Dermatology|April 16, 2013
Expression of gastrin-releasing peptide receptor in patients with cutaneous malignant melanomaB F Marrone, L Meurer, A Moretto, et al.
Mechanisms of Ageing and Development|April 20, 2001
Multidrug resistance gene expression during the murine ontogenyM Schiengold, L Schwantes, G Schwartsmann, et al.
The Oncologist|February 21, 2002
Targeting protein kinase C: new therapeutic opportunities against high-grade malignant gliomas?A B da Rocha, D R A Mans, A Regner, et al.
Journal of the National Cancer Institute|April 21, 1993
Reversal by interleukin-2 of alopecia universalis, mucocutaneous candidiasis, and sexual impotence in a patient with malignant thymomaE Sander, G Prolla, A R Marques, et al.
CNS & Neurological Disorders Drug Targets|May 5, 2010
Recent therapeutic advances for treating medulloblastoma: focus on new molecular targetsA L Schmidt, A L Brunetto, G Schwartsmann, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|November 12, 2002
Potentiation of carbon tetrachloride hepatotoxicity by pentosan polysulfate in ratsM C A Zim, T R Silveira, G Schwartsmann, et al.
Biochemical and Biophysical Research Communications|December 15, 1986
Growth inhibitory effects of 5-aza-2'-deoxycytidine in HL-60 promyelocytic leukemia cells resistant to differentiation inductionA Levva, G Schwartsmann, L C Boeije, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Minimal guidelines for the monitoring of early clinical trials (phase I-II) in Europe under CRC/EORTC/NCI joint agreementC Arrigo, I J Koier, J G McVie, et al.
Leukemia Research|August 12, 2008
Sodium butyrate enhances the cytotoxic effect of antineoplastic drugs in human lymphoblastic T-cellsM P dos Santos, G Schwartsmann, R Roesler, et al.
Pageof 9

Showing results (31-40 of 89) with videos related to

Sort By:
Pageof 9
Cancer Letters|October 26, 1999
Phenotype modulation of cellular UV-sensitivityM A Castro, G Schwartsmann, E A Bernard, et al.
Clinical and Experimental Dermatology|April 16, 2013
Expression of gastrin-releasing peptide receptor in patients with cutaneous malignant melanomaB F Marrone, L Meurer, A Moretto, et al.
Mechanisms of Ageing and Development|April 20, 2001
Multidrug resistance gene expression during the murine ontogenyM Schiengold, L Schwantes, G Schwartsmann, et al.
The Oncologist|February 21, 2002
Targeting protein kinase C: new therapeutic opportunities against high-grade malignant gliomas?A B da Rocha, D R A Mans, A Regner, et al.
Journal of the National Cancer Institute|April 21, 1993
Reversal by interleukin-2 of alopecia universalis, mucocutaneous candidiasis, and sexual impotence in a patient with malignant thymomaE Sander, G Prolla, A R Marques, et al.
CNS & Neurological Disorders Drug Targets|May 5, 2010
Recent therapeutic advances for treating medulloblastoma: focus on new molecular targetsA L Schmidt, A L Brunetto, G Schwartsmann, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|November 12, 2002
Potentiation of carbon tetrachloride hepatotoxicity by pentosan polysulfate in ratsM C A Zim, T R Silveira, G Schwartsmann, et al.
Biochemical and Biophysical Research Communications|December 15, 1986
Growth inhibitory effects of 5-aza-2'-deoxycytidine in HL-60 promyelocytic leukemia cells resistant to differentiation inductionA Levva, G Schwartsmann, L C Boeije, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Minimal guidelines for the monitoring of early clinical trials (phase I-II) in Europe under CRC/EORTC/NCI joint agreementC Arrigo, I J Koier, J G McVie, et al.
Leukemia Research|August 12, 2008
Sodium butyrate enhances the cytotoxic effect of antineoplastic drugs in human lymphoblastic T-cellsM P dos Santos, G Schwartsmann, R Roesler, et al.
Pageof 9